ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
kiwig
|
297 |
93K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
93K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
kiwig
|
297 |
93K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
93K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
kiwig
|
297 |
93K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
93K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
kiwig
|
297 |
93K |
16 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
93K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
kiwig
|
297 |
93K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
297
|
93K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Launch of Dapsone 5%, Gel in the United States
|
|
kiwig
|
40 |
11K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
40
|
11K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
kiwig
|
58 |
13K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
13K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
kiwig
|
37 |
6.5K |
2 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
37
|
6.5K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
kiwig
|
37 |
6.5K |
1 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
37
|
6.5K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Future Announcements
|
|
kiwig
|
37 |
6.5K |
0 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
37
|
6.5K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4D and Half Year Accounts
|
|
kiwig
|
25 |
7.2K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
25
|
7.2K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS PharmaQC Commercially Ready - Performance Finalised
|
|
kiwig
|
71 |
31K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
71
|
31K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS PharmaQC Commercially Ready - Performance Finalised
|
|
kiwig
|
71 |
31K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
71
|
31K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Freenome Raises $254M
|
|
kiwig
|
37 |
8.8K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
37
|
8.8K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
kiwig
|
247 |
73K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
73K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
kiwig
|
247 |
73K |
11 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
73K
|
11
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
kiwig
|
279 |
83K |
5 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
279
|
83K
|
5
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
kiwig
|
909 |
308K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
909
|
308K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
kiwig
|
91 |
34K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
91
|
34K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Blood based CRC test
|
|
kiwig
|
9 |
3.9K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
9
|
3.9K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
kiwig
|
91 |
34K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
34K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Freenome Raises $254M
|
|
kiwig
|
37 |
8.8K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
37
|
8.8K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ detects 19% more breast cancers than leading test
|
|
kiwig
|
91 |
34K |
18 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
34K
|
18
|
|
ASX - By Stock
|
RHY |
Re:
Freenome Raises $254M
|
|
kiwig
|
37 |
8.8K |
0 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
37
|
8.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Freenome Raises $254M
|
|
kiwig
|
37 |
8.8K |
3 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
37
|
8.8K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Freenome Raises $254M
|
|
kiwig
|
37 |
8.8K |
0 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
37
|
8.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Freenome Raises $254M
|
|
kiwig
|
37 |
8.8K |
4 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
37
|
8.8K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Proposed issue of securities - RHY
|
|
kiwig
|
31 |
10K |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
31
|
10K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Proposed issue of securities - RHY
|
|
kiwig
|
31 |
10K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
31
|
10K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Proposed issue of securities - RHY
|
|
kiwig
|
31 |
10K |
7 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
31
|
10K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
kiwig
|
29 |
9.4K |
0 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
29
|
9.4K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
kiwig
|
29 |
9.4K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.4K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
kiwig
|
29 |
9.4K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.4K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
kiwig
|
29 |
9.4K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.4K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
kiwig
|
29 |
9.4K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
29
|
9.4K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Why has Rhythm soared tfr on 11 cents to 15 cents in 4 trading sessions?
|
|
kiwig
|
8 |
2.8K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8
|
2.8K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
91
|
29K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
0 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
91
|
29K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
0 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
91
|
29K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
1 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
91
|
29K
|
1
|
|
ASX - By Stock
|
VR1 |
Re:
General Discussion
|
|
kiwig
|
188 |
68K |
5 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
188
|
68K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
0 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
91
|
29K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
2 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
91
|
29K
|
2
|
|
ASX - By Stock
|
VR1 |
Re:
General Discussion
|
|
kiwig
|
188 |
68K |
2 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
188
|
68K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
91
|
29K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
0 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
91
|
29K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
91
|
29K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
kiwig
|
91 |
29K |
3 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
91
|
29K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Strategy & Market Update
|
|
kiwig
|
20 |
12K |
4 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
20
|
12K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Receipt of Notice under Section 249D of the Corporations Act
|
|
kiwig
|
11 |
5.6K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
11
|
5.6K
|
0
|
|